title: Renal artery stenosis after kidney transplantation: diagnostic and therapeutic approach.
abstract: Transplant renal artery stenosis (TRAS) is a common complication after transplantation and an important cause of graft dysfunction. Many factors have been implicated as possible causes of TRAS, such as damage from trauma and atherosclerosis. We reviewed all 286 patients transplanted in our unit from January 1990 to July 1997 to study the prevalence, clinical features, and diagnostic and therapeutic approach. Thirteen patients with TRAS were identified, and their mean age was 40 +/- 15 years. The detected incidence was 4.5%. They were treated with triple therapy (prednisone, azathioprine and cyclosporine A). The mean age of the donors was 28 +/- 27 years. TRAS was diagnosed within nine months after transplant. All patients were studied with Doppler ultrasound, renography with captopril and angiography. The preferred initial therapy was percutaneous transluminal balloon renal angioplasty. Angioplasty was performed in four patients with good results. Two patients underwent surgery because angioplasty was not possible. Blood pressure control could be achieved with less antihypertensive medication after angioplasty. Transplantectomy was performed in one patient because of surgical complications. In conclusion, most patients with TRAS can be treated successfully with percutaneous transluminal angioplasty as the initial interventional treatment of choice for high-grade renal artery stenosis, and surgical revascularization is indicated when percutaneous transluminal angioplasty cannot be done or is unsuccessful.
authors.affiliation: Nephrology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Spain. 106027.1723@compuserve.com
authors.forename: M
authors.initials: M
authors.lastname: Rengel
authors.forename: G
authors.initials: G
authors.lastname: Gomes-Da-Silva
authors.forename: L
authors.initials: L
authors.lastname: Incháustegui
authors.forename: J L
authors.initials: JL
authors.lastname: Lampreave
authors.forename: R
authors.initials: R
authors.lastname: Robledo
authors.forename: A
authors.initials: A
authors.lastname: Echenagusia
authors.forename: J L
authors.initials: JL
authors.lastname: Vallejo
authors.forename: F
authors.initials: F
authors.lastname: Valderrábano
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001164:Arteriovenous Fistula / Q000000981:diagnostic imaging; D001794:Blood Pressure; D002102:Cadaver; D005500:Follow-Up Studies; D006801:Humans; D007083:Iliac Artery / Q000473:pathology / Q000601:surgery; D007668:Kidney / Q000098:blood supply; D016030:Kidney Transplantation; D008875:Middle Aged; D011183:Postoperative Complications / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D011877:Radionuclide Imaging; D012077:Renal Artery / Q000473:pathology / Q000601:surgery; D012078:Renal Artery Obstruction / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D017263:Technetium Tc 99m Mertiatide; D014019:Tissue Donors; D018615:Ultrasonography, Doppler, Color
chemical_list: D000959:Antihypertensive Agents; D017263:Technetium Tc 99m Mertiatide